Active Ingredient History
Medium-chain triglycerides (MCTs) are triglycerides with two or three fatty acids having an aliphatic tail of 6–12 carbon atoms, i.e. medium-chain fatty acids (MCFAs). Rich food sources for commercial extraction of MCTs include palm kernel oil and coconut oil. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Adenomatous Polyposis Coli (Phase 3)
Alcoholism (Phase 3)
alpha-Linolenic Acid (Phase 3)
Anti-Inflammatory Agents (Phase 3)
Atrial Fibrillation (Phase 3)
Blepharitis (Phase 4)
Carcinoma, Hepatocellular (Phase 2/Phase 3)
Cardiomyopathy, Dilated (Phase 3)
Cardiovascular Diseases (Phase 3)
Child Development (Phase 2)
Conjunctivitis (Phase 2)
Critical Illness (Phase 4)
Docosahexaenoic Acids (Phase 3)
Drug-Related Side Effects and Adverse Reactions (Phase 1/Phase 2)
Dry Eye Syndromes (Phase 4)
Eicosapentaenoic Acid (Phase 3)
Fatty Acids (Phase 3)
Fatty Liver (Phase 2)
Fibrosis (Phase 2/Phase 3)
Health Behavior (Phase 2)
Heart Failure (Phase 3)
Hypertriglyceridemia (Phase 4)
Inflammation (Phase 2)
Liver Cirrhosis (Phase 2/Phase 3)
Liver Neoplasms (Phase 4)
Maternal Exposure (Phase 2)
Multiple Sclerosis (Phase 1/Phase 2)
Obesity, Morbid (Phase 2)
Pancreatic Neoplasms (Phase 4)
Parenteral Nutrition (Phase 3)
Pressure Ulcer (Phase 4)
Preventive Health Services (Phase 3)
Preventive Medicine (Phase 3)
Prostatic Neoplasms (Phase 1/Phase 2)
SARS-CoV-2 (Phase 3)
Schizophrenia (Phase 4)
Stomach Neoplasms (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue